Steroids in Total Knee Arthroplasty

Adequate pain control after total knee replacement (TKA) is of great importance not only to
maximize patient comfort, but also to ensure optimal outcomes after surgery. This study is
designed to assess whether the use of two small doses of intravenous (IV) steroids around the
time of surgery decrease a patient's pain or use of pain medication. Secondly, the
investigators will also determine if the use of these steroids as part of a multimodal pain
management strategy leads to improved patient outcomes, including pain, nausea and vomiting,
knee function and length of stay in the hospital after surgery. The study will compare the
effect of two different doses of IV dexamethasone given preoperatively before TKA, when
compared to placebo.

Inclusion Criteria:

- Patients undergoing primary total joint arthroplasty of the knee

- Adult patients ages 18-100 years

- Patients must have smart phone and/or device for app usage

Exclusion Criteria:

- Current chronic steroid use

- Patients undergoing revision knee surgery

- Patients ambulating preoperatively with assistive devices

- Patients with avascular necrosis of the operative knee

- Patients with a history of an adverse reaction to glucocorticoid steroids

- Patients unable to provide informed consent

- Patients with inflammatory arthritis

- Prisoners

- Current smokers

- Patients <18 years of age

- Any patient with a complicated postoperative course that requires transfer to the
Intensive Care Unit (ICU) or to another facility for further management will be
removed from the study.

- Any contraindication that would prevent the patient from being treated with the
standard multimodal postoperative pain management regimen History of infection of
surgical knee.

- Patients with diabetes.

- Patients that have an intolerance to Toradol.

- Patients that do not have smart phone and/or device for app usage